Opioid Learning Institute

Sign up for the mailing list

☰
  • Education & Training
    • Providers
    • eLearning Courses
    • Case Reviews
    • Webinars
    • Community
    • eLearning Courses
  • Resource Library
    • Assessments
    • General
    • Harm Reduction
    • Overdose Prevention
    • MAT
    • Pain Management
    • Prescribing Guidelines
    • Tapering
    • Treatment
    • DC Opioid Dashboard
  • News & Events
    • News
    • Calendar of Events
  • About the Institute
    • HAHSTA
    • HealthHIV
    • Project Staff
  • Contact
  • f
  • l
  • i

Category: Science Highlight

Using Smartphone Apps to Reach Gay and Bisexual Men at Risk for HIV

Finding better ways to reach people at higher risk of HIV for testing and engagement with HIV prevention and treatment services is a critical…

Finding better ways to reach people at higher risk of HIV for testing and engagement with HIV prevention and treatment services is a critical...
Author Syndicated Feed Provided by NIDAPosted on March 1, 2021Categories Science Highlight

Co-located HIV Services Can Help Women Who Inject Drugs Access PrEP, Study Shows

Daily, PrEP (pre-exposure prophylaxis medication), is proven to prevent HIV transmission from injection drug use or sex.

Daily, PrEP (pre-exposure prophylaxis medication), is proven to prevent HIV transmission from injection drug use or sex.
Author Syndicated Feed Provided by NIDAPosted on January 22, 2021Categories Science Highlight

Substance Use Status Important When Developing HIV Therapies

Animal studies suggest that subjects with HIV who suffer from opioid use disorders may have higher viral reservoirs in the central nervous system than…

Animal studies suggest that subjects with HIV who suffer from opioid use disorders may have higher viral reservoirs in the central nervous system than...
Author Syndicated Feed Provided by NIDAPosted on December 23, 2020Categories Science Highlight

Unraveling neuroHIV in the Presence of Substance Use Disorders

These reviews address how each of these addictive substances and HIV individually or collectively affect the immune system and subsequent clinical and…

These reviews address how each of these addictive substances and HIV individually or collectively affect the immune system and subsequent clinical and...
Author Syndicated Feed Provided by NIDAPosted on December 15, 2020Categories Science Highlight

Elite Controllers May Hold Key to an HIV Cure

“Science” Magazine Breakthrough of the Year Runner Up for 2020

"Science" Magazine Breakthrough of the Year Runner Up for 2020
Author Syndicated Feed Provided by NIDAPosted on December 2, 2020Categories Science Highlight

HIV and Methamphetamine Use: Double Jeopardy for Transmission of the Novel Coronavirus.

The authors suggest that co-occurring methamphetamine use and HIV present a double jeopardy for COVID.

The authors suggest that co-occurring methamphetamine use and HIV present a double jeopardy for COVID.
Author Syndicated Feed Provided by NIDAPosted on November 23, 2020Categories Science Highlight

Gaps in Substance Use Treatment Services for HIV Patients Around the Globe

Substance use is common among people living with HIV and is associated with less successful HIV treatment outcomes. Integrating substance use services…

Substance use is common among people living with HIV and is associated with less successful HIV treatment outcomes. Integrating substance use services...
Author Syndicated Feed Provided by NIDAPosted on September 15, 2020Categories Science Highlight

Recent Posts

  • Childhood Caffeine Exposure May Negatively Affect Cognitive Functioning
  • Office of Research Training, Diversity, and Disparities Newsletter, March/April 2021
  • Medications for Opioid Overdose, Withdrawal & Addiction
  • Mourning the Loss of a Great Addiction Pioneer
  • Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse

Recent Comments

    Archives

    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • June 2020
    • April 2020
    • February 2020
    • July 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • October 2018
    • June 2018
    • April 2018
    • October 2017
    • August 2017
    • April 2017
    • March 2017
    • February 2017
    • October 2016
    • May 2016
    • January 2016
    • November 2015
    • February 2015

    Categories

    • Abortion
    • Aging
    • Audio
    • Biden Administration
    • California
    • Capitol Desk
    • CDC
    • Children's Health
    • Chronic Disease Care
    • Courts
    • COVID-19
    • Doctors
    • Drug Costs
    • Elections
    • Emerging Trend
    • Global Health Watch
    • Health Care Costs
    • Health Care Reform
    • Health Industry
    • Health IT
    • HHS
    • Hospitals
    • Infographic
    • Insurers
    • Iowa
    • KHN & PolitiFact HealthCheck
    • KHN's 'What The Health?'
    • Letter To The Editor
    • Marijuana
    • Medicaid
    • Medicare
    • Mental Health
    • Missouri
    • Multimedia
    • New York
    • News Release
    • NIDA Notes
    • Nora's Blog
    • Obamacare Plans
    • Open Enrollment
    • Opioids
    • Out-Of-Pocket Costs
    • Pennsylvania
    • Pharmaceuticals
    • Podcasts
    • Prescription Drugs
    • Public Health
    • Research Training Newsletter
    • Science Highlight
    • States
    • Substance Abuse
    • Telemedicine
    • The Health Law
    • Trump Administration
    • U.S. Congress
    • Vaccines
    • Vaping
    • Women's Health

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    A PROJECT OF:

    DC Health HealthHIV

    This program is funded wholly, or in part, by the Government of the District of Columbia, DC Health, HIV/AIDS, Hepatitis, STD, TB Administration (HAHSTA).

    2000 S St. NW
    Washington D.C. 20009

    202-232-6749

    Opioids@HealthHIV.org

    • f
    • l
    • i